P. Birner
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Lymphatic System and Diseases
Papers in
- Co-authors
- Georg Oberhuber (7 shared papers)Andreas Obermair (4 shared papers)G. Breitenecker (7 shared papers)Martin Schindl (1 shared paper)Monika Schindl (6 shared papers)SEBASTIAN FRIEDRICH SCHOPPMANN (8 shared papers)Matthias Preusser (14 shared papers)R. Jakesz (3 shared papers)
In The Last Decade
P. Birner
39 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 75
- Cancer Research 329
- Oncology 404
- Internal Medicine 42
- Genetics 72
- Neurology 107
Countries citing papers authored by P. Birner
This map shows the geographic impact of P. Birner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Birner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Birner more than expected).
Fields of papers citing papers by P. Birner
This network shows the impact of papers produced by P. Birner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Birner. The network helps show where P. Birner may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Birner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. | 2001 | 278 |
| 2 | Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. | 2001 | 168 |
| 3 | Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. | 2001 | 143 |
| 4 | 2002 | 83 | |
| 5 | Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. | 2001 | 75 |
| 6 | 2001 | 71 | |
| 7 | 2003 | 64 | |
| 8 | 2002 | 56 | |
| 9 | 2004 | 56 | |
| 10 | 2018 | 54 | |
| 11 | 2009 | 52 | |
| 12 | Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. | 2000 | 44 |
| 13 | 2005 | 43 | |
| 14 | 2014 | 43 | |
| 15 | 2014 | 36 | |
| 16 | 2009 | 28 | |
| 17 | Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer. | 2002 | 26 |
| 18 | 2011 | 25 | |
| 19 | 2012 | 25 | |
| 20 | 2017 | 23 |
About P. Birner
P. Birner is a scholar working on Oncology, Genetics, Neurology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Brain Metastases and Treatment (6 papers), Glioma Diagnosis and Treatment (6 papers), Lymphatic System and Diseases (5 papers), Cervical Cancer and HPV Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), HER2/EGFR in Cancer Research (3 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). The work is most often cited by research in Cancer Research (329 citations), Oncology (404 citations), Internal Medicine (42 citations), Genetics (72 citations) and Neurology (107 citations). P. Birner has collaborated with scholars based in Austria, Germany and Italy. Frequent co-authors include Georg Oberhuber, Andreas Obermair, G. Breitenecker, Martin Schindl, Monika Schindl, SEBASTIAN FRIEDRICH SCHOPPMANN, Matthias Preusser, R. Jakesz, Michael Gnant and Johannes Andreas Hainfellner. Their work appears in journals such as Journal of Neuro-Oncology, Annals of Oncology, European Journal of Cancer, Strahlentherapie und Onkologie and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.